Assembly Biosciences
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $8,212 | $42,469 | $10,789 | $9,626 |
Gross Profit | 8,186 | 42,437 | 10,789 | -6,499 |
EBITDA | -11,370 | 19,831 | -9,164 | -11,061 |
EBIT | -11,396 | 19,799 | -9,196 | -11,093 |
Net Income | -9,079 | 22,090 | -9,196 | -10,198 |
Net Change In Cash | 8,212 | 42,469 | 10,789 | 9,626 |
Free Cash Flow | -22,116 | 14,213 | -15,175 | -16,758 |
Cash | 31,120 | 58,450 | 22,534 | 24,006 |
Basic Shares | 16,900 | 11,210 | 7,655 | 7,655 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $72,303 | $28,520 | $7,163 | $0 |
Gross Profit | 72,174 | 28,520 | -41,737 | -498 |
EBITDA | -11,989 | -45,291 | -64,196 | -93,616 |
EBIT | -12,118 | -45,420 | -64,646 | -94,114 |
Net Income | -6,122 | -40,177 | -61,228 | -92,070 |
Net Change In Cash | 72,303 | 28,520 | 7,163 | 0 |
Cost of Revenue | 6,791 | |||
Free Cash Flow | -41,159 | -51,145 | 22,488 | -84,565 |
Cash | 58,450 | 38,344 | 19,841 | 52,418 |
Basic Shares | 11,210 | 6,004 | 4,577 | 4,034 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.54 |
2025-12-31 | $2.48 |
2025-09-30 | -$0.72 |
2025-06-30 | -$1.33 |